Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges

Waleed H Almalki; Saad Alghamdi; Abdulaziz Alzahrani; Wenzhi Zhang

doi:10.1016/j.drudis.2020.12.018

Back

Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges

Journal article

Peer reviewed

Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges

Waleed H Almalki, Saad Alghamdi, Abdulaziz Alzahrani and Wenzhi Zhang

Drug discovery today, Vol.26(3), pp.826-835

03/2021

DOI: https://doi.org/10.1016/j.drudis.2020.12.018

PMID: 33383212

Abstract

Animals

Cerebral Infarction - diagnosis

Cerebral Infarction - drug therapy

Cerebral Infarction - physiopathology

Drug Carriers - chemistry

Drug Delivery Systems

Drug Development

Humans

Nanostructures

Stroke - diagnosis

Stroke - drug therapy

Stroke - physiopathology

Theranostic Nanomedicine

Interest is increasing in the use of nanotheranostics as diagnosis, imaging and therapeutic tools for stroke management, but movement to the clinic remains challenging.

Metrics

1 Record Views

Details

Title: Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges
Creators - without role: Waleed H Almalki - Umm al-Qura University
Saad Alghamdi - Umm al-Qura University
Abdulaziz Alzahrani - Al Baha University
Wenzhi Zhang - Senior Research Scientist, Inn Research Sdn. Bhd., Subang Jaya, Selangor, Malaysia
Publication Details: Drug discovery today, Vol.26(3), pp.826-835
Identifiers: 9912304108331
Academic Unit: King Saud Bin Abdulaziz University for Health Sciences; Umm Al Qura University
Language: English
Resource Type: Journal article